Barclays’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Buy |
6,328
+1,016
| +19% | +$21K | ﹤0.01% | 3747 |
|
|
2025
Q1 | $92K | Sell |
5,312
-110,359
| -95% | -$1.91M | ﹤0.01% | 3717 |
|
|
2024
Q4 | $3.14M | Buy |
115,671
+34,533
| +43% | +$937K | ﹤0.01% | 1922 |
|
|
2024
Q3 | $3.56M | Buy |
81,138
+40,915
| +102% | +$1.8M | ﹤0.01% | 1763 |
|
|
2024
Q2 | $1.58M | Sell |
40,223
-41,039
| -51% | -$1.61M | ﹤0.01% | 1853 |
|
|
2024
Q1 | $3.48M | Buy |
81,262
+80,430
| +9,667% | +$3.45M | ﹤0.01% | 1560 |
|
|
2023
Q4 | $34K | Sell |
832
-5,000
| -86% | -$204K | ﹤0.01% | 3890 |
|
|
2023
Q3 | $294K | Buy |
5,832
+4,700
| +415% | +$237K | ﹤0.01% | 2834 |
|
|
2023
Q2 | $47K | Buy |
+1,132
| New | +$47K | ﹤0.01% | 3702 |
|